Literature DB >> 17879626

Penile squamous cell carcinoma: anatomic, pathologic and viral studies in Paraguay (1993-2007).

Elsa F Velazquez1, Antonio L Cubilla.   

Abstract

In developed countries, penile squamous cell carcinoma (SCC) account for < 1% of all malignancies in men. It is more frequent in rural populations of Africa, Asia and Latin America, where it may constitute nearly 10% of all carcinomas. In Paraguay, approximately 30-40 new cases are diagnosed per year. Different subtypes of penile carcinomas have been described. Most SCCs are of the usual type (60%). Less frequent variants include basaloid (10%), warty (10%), papillary (15%), verrucous (3%), sarcomatoid (4%) and adenosquamous (1%). Mixed forms also exist. Because there is a correlation between histologic subtype and biologic behavior, accurate subtyping is important. The prevalence of human papillomavirus (HPV) in invasive SCC is approximately 42%, with a strong association of HPV and basaloid and warty variants. Among the most important prognostic factors are histologic grade and depth of invasion. It is important for surgical pathologists to know the anatomy of the penis and possible routes of tumor spread because negative resection margins are crucial to avoid local recurrences. The most frequently involved margins are the urethra and periurethral tissues, including Buck's fascia. Probable precursor lesions of penile carcinoma include squamous hyperplasia, low and high grade squamous intraepithelial neoplasia and lichen sclerosus.

Entities:  

Mesh:

Year:  2007        PMID: 17879626

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  8 in total

1.  Prognostic factors in patients with penile cancer after surgical management.

Authors:  Shuguang Wen; Wenbiao Ren; Bichen Xue; Yi Fan; Yongjun Jiang; Chunming Zeng; Yujia Li; Xiongbing Zu
Journal:  World J Urol       Date:  2018-01-03       Impact factor: 4.226

2.  Penile cancer: epidemiology and treatment.

Authors:  Gustavo Cardoso Guimarães; Rafael Malagoli Rocha; Stenio Cassio Zequi; Isabela Werneck Cunha; Fernando Augusto Soares
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

3.  DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma.

Authors:  Oliver J Kayes; Marco Loddo; Nimish Patel; Pranav Patel; Suks Minhas; Gareth Ambler; Alex Freeman; Alex Wollenschlaeger; David J Ralph; Kai Stoeber; Gareth H Williams
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

4.  Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers.

Authors:  Hellen Kuasne; Ilce Mara de Syllos Cólus; Ariane Fidelis Busso; Hector Hernandez-Vargas; Mateus Camargo Barros-Filho; Fabio Albuquerque Marchi; Cristovam Scapulatempo-Neto; Eliney Ferreira Faria; Ademar Lopes; Gustavo Cardoso Guimarães; Zdenko Herceg; Silvia Regina Rogatto
Journal:  Clin Epigenetics       Date:  2015-04-18       Impact factor: 6.551

5.  A warty lesion on the penis.

Authors:  Kara Melissa T Torres; Dennis C Polley; Filamer Kabigting; Dirk M Elston
Journal:  Indian Dermatol Online J       Date:  2016 Mar-Apr

6.  P16INK4a expression in patients with penile cancer.

Authors:  Vicenilma de Andrade Martins; Jaqueline Diniz Pinho; Antonio Augusto Lima Teixeira Júnior; Leudivan Ribeiro Nogueira; Fábio França Silva; Victor Eduardo Maulen; André Salim Khayat; José de Ribamar Rodrigues Calixto; Herikson Araújo Costa; Leandra Naira Zambelli Ramalho; Gyl Eanes Barros Silva
Journal:  PLoS One       Date:  2018-10-12       Impact factor: 3.240

7.  Warty (condylomatous) carcinoma of the back: a case report.

Authors:  Ilou Park; Sung Hoon Koh; Hee Jeong Lee
Journal:  J Surg Case Rep       Date:  2021-05-05

8.  Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types.

Authors:  Stefano Menzo; Andrea Ciavattini; Patrizia Bagnarelli; Katia Marinelli; Stefano Sisti; Massimo Clementi
Journal:  BMC Microbiol       Date:  2008-07-04       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.